GnRH激动剂与抑郁症和自杀/自我伤害的关联:FAERS药监调查研究
Jinhua Liu1,2, Liping Xue1,2, Ruolin Chen3
1Department of Pharmacy, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou 350001, China.
Endocrine connections
|March 2, 2026
概括
这项研究发现,淋巴激素释放激素激动剂 (GnRH-a) 可能与抑郁症和自杀/自伤 (DASSI) 相关,特别是在女性和年轻患者中. 需要进一步的研究来证实这些发现.
科学领域:
- 药物监督 药物监督 药物监督
- 不良事件分析不良事件分析
- 临床精神病学 临床精神病学
背景情况:
- 人们一直在争论性腺激素释放激素激动剂 (GnRH-a) 与抑郁症和自杀/自伤 (DASSI) 之间的关联.
- 这项研究利用了FDA不良事件报告系统 (FAERS) 数据库来调查这种关系.
研究的目的:
- 为了检查GnRH-a和DASSI之间的潜在联系.
- 分析DASSI发病的时间,并确定风险因素.
主要方法:
- 对FAERS数据 (2004Q1-2024Q1) 对与GnRH-a.相关的DASSI事件进行了回顾性分析.
- 进行了时间到发病 (TTO) 和不成比例性分析 (DPA).
- 评估了联合药物对DASSI的影响.
主要成果:
- 确定了5454个与GnRH-a相关的DASSI病例.
- 与男性和老年人相比,在女性,儿童和成年人中观察到较早的DASSI发病.
- 在女性和瘤患者中发现了更强烈的DASSI信号;联合药物分析显示了抑郁相互作用.
结论:
- FAERS数据表明,与某些GnRH-a疗法有关的DASSI报告不成比例的潜在信号,特别是在特定的人口统计数据中.
- 这些发现是产生假设的,并且由于无法推断因果关系,因此需要谨慎解释.
- 结果可以为临床意识和风险监测策略提供信息,但需要通过流行病学研究来确认.
相关概念视频
G-protein Coupled Receptors
133.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
133.1K
Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
Pharmacovigilance
1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.9K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.9K
Antidepressant Drugs: Overview
1.8K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.8K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
1.1K
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.1K


